Mayne Pharma Group(DE:HG6)
€1.92-0.06 (-3.03%)
DE:HG6
Mayne Pharma Group ownership
€1.92
At close:-0.06 (-3.03%)
Mayne Pharma Group (HG6) Ownership - Who Owns Mayne Pharma Group?
0 Followers
Mayne Pharma Group (HG6) Ownership Overview
- 0.31% Insiders
- 3.47% Mutual Funds
- <0.01% Other Institutional Investors
- 3.40% ETFs
- 92.81% Public Companies and Individual Investors
The ownership structure of Mayne Pharma Group (DE:HG6) stock is a mix of institutional, retail, and individual investors. Approximately 6.88% of the company’s stock is owned by Institutional Investors, 0.31% is owned by Insiders, and 92.81% is owned by Public Companies and Individual Investors.
The ownership structure of Mayne Pharma Group (DE:HG6) stock is a mix of institutional, retail, and individual investors. Approximately 6.88% of the company’s stock is owned by Institutional Investors, 0.31% is owned by Insiders, and 92.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 22, 2025 | Shawn Patrick O’brien | AU$401,338 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 2,201,024 | Institution | 2.69% | 4,657,367 |
| Vanguard Star Funds | 1,041,102 | Institution | 1.27% | 2,202,972 |
| Vanguard Tax-managed Funds | 794,498 | Institution | 0.97% | 1,681,158 |
| Dfa Investment Dimensions Group Inc | 601,551 | Institution | 0.73% | 1,272,882 |
| Vanguard International Equity Index Funds | 355,722 | Institution | 0.43% | 752,708 |
| Shawn Patrick O’brien | 257,573 | Insider | 0.31% | 545,024 |
| Avantis | 201,580 | Institution | 0.25% | 426,543 |
| Schwab | 133,423 | Institution | 0.16% | 282,323 |
| Dimensional | 117,233 | Institution | 0.14% | 248,065 |
| Ishares | 68,016 | Institution | 0.08% | 143,922 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 1,041,102 | Institution | 1.27% | 2,202,972 |
| Vanguard Tax-managed Funds | 794,498 | Institution | 0.97% | 1,681,158 |
| Dfa Investment Dimensions Group Inc | 601,551 | Institution | 0.73% | 1,272,882 |
| Vanguard International Equity Index Funds | 355,722 | Institution | 0.43% | 752,708 |
| Old Westbury Funds Inc | 42,819 | Institution | 0.05% | 90,605 |
| John Hancock Variable Insurance Trust | 4,957 | Institution | <0.01% | 10,489 |
| American Century Etf Trust | 2,120 | Institution | <0.01% | 4,486 |
FAQ
Who Owns Mayne Pharma Group (DE:HG6)?
According to the latest TipRanks data, approximately 6.88% of the company's stock is held by institutional investors, 0.31% is held by insiders, and 92.81% is held by public companies and individual investors.
What percentage of Mayne Pharma Group (DE:HG6) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.88% of Mayne Pharma Group (DE:HG6) stock is held by institutional investors: 3.47% by mutual funds, 3.40% by ETFs and <0.01% by other institutional investors.
What percentage of Mayne Pharma Group (DE:HG6) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.81% of Mayne Pharma Group (DE:HG6) stock is held by public companies and individual investors.
Who owns the most shares of Mayne Pharma Group (DE:HG6)?
Vanguard owns the most shares of Mayne Pharma Group (DE:HG6).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
